Is Gilead Sciences Stock Outperforming the Dow?

Gilead Sciences, Inc. (GILD), founded in 1987, has long stood as one of America’s most influential biopharmaceutical powerhouses, a company that built its legacy by tackling humanity’s most complex diseases. Headquartered in Foster City, California, it carved its name through breakthroughs in HIV/AIDS treatments, transformed global outcomes in hepatitis B and C, and stepped up during the COVID-19 crisis with Veklury. Today, oncology and inflammatory diseases form Gilead’s next frontiers, expanding the comp ...